NCT02899286 Efficacy and Safety Study of Recombinant Human Arginase 1 in Patients With Relapsed or Refractory Acute Myeloid Leukemia Status UNKNOWN Phase PHASE2
NCT02892318 A Study Evaluating the Safety and Pharmacology of Atezolizumab Administered in Combination With Immunomodulatory Agents in Participants With Acute Myeloid Leukemia (AML) Status COMPLETED Phase PHASE1
NCT02891278 Sertraline and Cytosine Arabinoside in Adults With Relapsed and Refractory AML Status COMPLETED Phase PHASE1
NCT02890758 Phase I Trial of Universal Donor NK Cell Therapy in Combination With ALT803 Status COMPLETED Phase PHASE1
NCT02878785 Decitabine and Talazoparib in Untreated AML and R/R AML Status COMPLETED Phase PHASE1/PHASE2
NCT02877277 Epigenetics, Vitamin C and Abnormal Hematopoiesis - Pilot Study Status COMPLETED Phase NA
NCT02875093 Ph 1 Study of ADI-PEG 20 Plus Low Dose Cytarabine in Older Patients With AML Status TERMINATED Phase PHASE1
NCT02873338 Dociparstat Sodium (CX-01) Combined With Standard Induction Therapy for Newly Diagnosed Acute Myeloid Leukemia Status COMPLETED Phase PHASE2
NCT02870777 MRD-directed Therapy for Low-risk and Intermediate-risk AML. Status COMPLETED Phase PHASE2/PHASE3
NCT02867891 Sorafenib In Relapse of FMS-like Tyrosine Kinase 3 (FLT3)-Internal Tandem Duplication (ITD) AML Trial Status COMPLETED Phase N/A
NCT02864290 A Study to Evaluate Escalating Doses of ASP1235 (AGS62P1) Given as Monotherapy in Subjects With Acute Myeloid Leukemia (AML) Status TERMINATED Phase PHASE1
NCT02863458 DNA Hypomethylating Agents and Lenalidomide in Elderly Patients With Myeloid Malignancies in the US Status WITHDRAWN Phase N/A
NCT02863302 Reflexology: An Intervention for Acute Myeloid Leukemia(AML) Patients Status UNKNOWN Phase NA
NCT02861651 Molecular Characterization of Acute Erythroid Leukemia (M6-AML) Using Targeted Next-generation Sequencing Status COMPLETED Phase N/A
NCT02860598 Observatory of the Prescription of Erythropoietin as Treatment of Anemia Induced by Chemotherapy or Allograft Conditioning Among the Patients With a Haematological Malignancy Status UNKNOWN Phase N/A
NCT02859948 A Study of SKLB1028 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia Status UNKNOWN Phase PHASE1
NCT02856204 Shotgun Sequencing in Diagnosing Febrile Neutropenia in Patients With Acute Myeloid Leukemia Status COMPLETED Phase N/A
NCT02856178 Study on Safety and Pharmacokinetics of Intravenous F901318 for Fungal Prophylaxis in AML Patients Status WITHDRAWN Phase PHASE1/PHASE2
NCT02848248 A Safety Study of SGN-CD123A in Patients With Acute Myeloid Leukemia Status TERMINATED Phase PHASE1